HWAM
TSVT

Hennion & Walsh Asset Management’s 2seventy bio TSVT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,238
Closed -$63.7K – 876
2023
Q3 		$63.7K Sell
16,238
-3,206
-16% -$21K ﹤0.01% 792
2023
Q2 		$197K Sell
19,444
-14,015
-42% -$148K 0.01% 752
2023
Q1 		$341K Sell
33,459
-939
-3% -$10.7K 0.02% 605
2022
Q4 		$322K Buy
34,398
+3,427
+11% +$48.3K 0.02% 604
2022
Q3 		$451K Sell
30,971
-785
-2% -$11.7K 0.03% 501
2022
Q2 		$419K Buy
31,756
+1,617
+5% +$22K 0.03% 528
2022
Q1 		$514K Buy
+30,139
New +$511K 0.03% 510

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Hennion & Walsh Asset Management's TSVT Position: Q4 2023 in Review

Hennion & Walsh Asset Management sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 16,238 shares — an estimated $63.7K sold.

Hennion & Walsh Asset Management first reported a position in TSVT in Q1 2022 and held it in 7 quarters. The position peaked at $514K in Q1 2022. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Hennion & Walsh Asset Management reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 16,238 2seventy bio shares in Q4 2023, an estimated $63.7K.
  • Hennion & Walsh Asset Management first reported a position in 2seventy bio in Q1 2022 and held it in 7 quarters.
  • Hennion & Walsh Asset Management's 2seventy bio position peaked at $514K in Q1 2022.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.